HUMAN EPIDIDYMIS PROTEIN 4 AS BIOMARKER FOR THE DIFFERENTIATION BETWEEN PRIMARY OVARIAN CANCER AND OVARIAN METASTASES

被引：0
作者：
Boldingh, Q. J. J. [1 ]
Stiekema, A. [1 ]
Lok, C. A. R. [1 ]
Boot, H. [2 ]
van Driel, W. J. [1 ]
Kenter, G. G. [1 ]
Korse, C. M. [2 ]
机构：
[1] Dutch Canc Inst, Ctr Gynecol Oncol Amsterdam, Amsterdam, Netherlands
[2] Dutch Canc Inst, Antoni van Leeuwenhoek Hosp, Amsterdam, Netherlands
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-0869
引用
收藏
页码：280 / 281
页数：2
相关论文
共 50 条
  • [41] Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix
    Ribeiro, Jennifer R.
    Gaudet, Hilary M.
    Khan, Mehreen
    Schorl, Christoph
    James, Nicole E.
    Oliver, Matthew T.
    DiSilvestro, Paul A.
    Moore, Richard G.
    Yano, Naohiro
    FRONTIERS IN ONCOLOGY, 2018, 7
  • [42] Accuracy of Serum Human Epididymis Protein 4 in Ovarian Cancer Diagnosis A Systematic Review and Meta-Analysis
    Lacerda Macedo, Ana Cristina
    da Rosa, Maria Ines
    Lumertz, Sueli
    Medeiros, Lidia Rosi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (07) : 1222 - 1231
  • [43] Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review
    Ferraro, Simona
    Braga, Federica
    Lanzoni, Monica
    Boracchi, Patrizia
    Biganzoli, Elia Mario
    Panteghini, Mauro
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (04) : 273 - 281
  • [44] SPROUTY 2 PROTEIN, BUT NOT SPROUTY 4, IS AN INDEPENDENT PROGNOSTIC BIOMARKER FOR HUMAN EPITHELIAL OVARIAN CANCER
    Masoumi-Moghaddam, S.
    Amini, A.
    Morris, D. Lawson
    ANNALS OF ONCOLOGY, 2015, 26 : 22 - 22
  • [45] Synchronous Primary Breast and Ovarian Cancer with Ovarian Cancer Metastases to a Breast Sentinel Lymph Node
    Fadare, Oluwole
    Gill, Stephen A.
    BREAST JOURNAL, 2009, 15 (02) : 204 - 205
  • [46] Human epididymis protein 4 (HE4) as a new tumour marker for diagnosis of ovarian carcinoma
    Colak, A.
    Dikmen, Z. G.
    Basaran, D.
    Tuncer, S.
    Akbiyik, F.
    FEBS JOURNAL, 2012, 279 : 117 - 117
  • [47] Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
    Uno, Masaya
    Matsuo, Rie
    Maezawa, Naoki
    Kato, Tomoyasu
    OBSTETRICS & GYNECOLOGY SCIENCE, 2023, 66 (04) : 290 - 299
  • [48] Diagnostic Value of Human Epididymis Protein 4 Compared with Mesothelin for Ovarian Cancer: a Systematic Review and Meta-analysis
    Lin, Jia-Ying
    Qin, Jin-Bao
    Li, Xiao-Yan
    Dong, Ping
    Yin, Bing-De
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (11) : 5427 - 5432
  • [49] Targeting and neutralizing human epididymis protein 4 by novel nanobodies to suppress ovarian cancer cells and attenuate cisplatin resistance
    Yu, Jianli
    Guo, Yang
    Gu, Yi
    Li, Fei
    Song, Haipeng
    Nian, Rui
    Fan, Xiying
    Liu, Wenshuai
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 199 : 298 - 306
  • [50] Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis
    Zhen, Shuai
    Bian, Li-Hong
    Chang, Li-Li
    Gao, Xin
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (04) : 559 - 566
12345